New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis

Press/Media

Period	19 May 2024

Media coverage

Title	New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis
Media name/outlet	Yahoo! Finance
Country/Territory	United States
Date	19/05/24
URL	https://finance.yahoo.com/news/phase-2a-clinical-trial-results-181200925.html
Persons	Michael Maher